Analysis of urinary kallikrein-related peptidase 13 for monitoring bladder cancer-Reference-Cited by-同舟云学术

Analysis of urinary kallikrein-related peptidase 13 for monitoring bladder cancer

Published:2021-11-11 Issue:8 Volume:26 Page:770-779
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Gruba Natalia¹,Rachubik Patrycja²,Piwkowska Agnieszka²³,Lesner Adam¹

Affiliation:

1. Department of Environmental Technology, Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland

2. Laboratory of Molecular and Cellular Nephrology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Gdańsk, Poland

3. Department of Molecular Biotechnology, Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland

Funder

University of Gdansk

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2021.1999502

Reference50 articles.

1. Adam, G., Kreutzer, P.J.S., Yang, H., 2021. Standard practices for Fmoc-based solid-phase peptide synthesis in the Nowick Laboratory. Available from: https://www.chem.uci.edu/∼jsnowick/groupweb/files/Standard_practices_for_Fmoc_based_solid_phase_peptide_synthesis_in_the_Nowick_Laboratory_V_1point6.pdf [Accessed 27 May 2021].

2. The Human Plasma Proteome

3. Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates

4. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Class of KLK13 Inhibitors Cysteine Knot;SSRN Electronic Journal;2022